![]() |
|
![]() |
Severe Combined Immunodeficiency DiseaseCell-mediated (T-cell) and humoral (B-cell) immunity are either deficient or absent in severe combined immunodeficiency disease (SCID), which predisposes the patient to infection from all classes of microorganisms during infancy. Defective B-cell and T-cell function may also cause other immunodeficiency disorders. Three types of SCID have been identified: reticular dysgenesis, the most severe type, in which the hematopoietic stem cell fails to differentiate into lymphocytes and granulocytes; Swiss-type agammaglobulinemia, in which the hematopoietic stem cell fails to differentiate into lymphocytes alone; and enzyme deficiency, such as adenosine deaminase deficiency, in which the buildup of toxic products in the lymphoid tissue causes damage and subsequent dysfunction. SCID affects more males than females and occurs in 1 in every 100,000 to 500,000 births. Most untreated infants die of infection within 1 year of birth. CausesSCID is usually transmitted as an autosomal recessive trait, although it may be X-linked. In most cases, the genetic defect seems associated with failure of the stem cell to differentiate into T and B cells. Many molecular defects, such as mutation of the kinase ZAP70, can cause SCID. X-linked SCID results from a mutation of a subunit of the interleukin (IL)-2, IL-4, and IL-7 receptors. Less commonly, SCID results from enzyme deficiency. Another theory is that the thymus or bursa equivalent fails to develop normally or that there is a defect in the thymus and bone marrow, which are responsible for T- and B-cell development. Symptoms Symptoms of SCID usually become apparent within the first year. The following are the most common symptoms of SCID. However, each child may experience symptoms differently. Symptoms may include:
Diagnostic testsDefective humoral immunity is hard to detect before an infant reaches age 5 months. Before that age, ever normal infants have only small amounts of serum IgM and IgA, and normal IgG levels merely reflect maternal IgG. Tests that show a severely diminished or absent T-cell number and function and a lymph node biopsy that shows an absence of lymphocytes can confirm a diagnosis of SCID. TreatmentThe goal of treatment is to restore immune response and prevent infection. Specific antibiotic therapy is used to treat infection. The patient needs histocompatible bone marrow transplantation to correct immunodeficiency. Bone marrow cells must be matched for histocompatibility, using both human leukocyte antigen and mixed leukocyte culture, so siblings usually serve as donors. Parental marrow can now be used successfully after it's depleted of T cells, which could cause fatal acute graft-versus-host disease. T cells are removed with monoclonal antibodies or lectin columns. Immunoglobulin may be given I.V. with dosages varying according to the severity of the illness. Fetal thymus and liver transplantation have met with limited success. Immune globulin may also play a role in treatment. Some SCID infants have received long-term protection by being isolated in a completely sterile environment. This approach doesn't work for an infant who already has recurring infections. |
|
© Doctor-clinic.org. All rights reserved. Bookmark This Page: Disclaimer :- The materials in this web site are in no way intended to replace the professional medical care, advice, diagnosis or treatment of a doctor. The web site does not have answers to all problems. Answers to specific problems may not apply to everyone. If you notice medical symptoms or feel ill, you should consult your doctor . We will not be liable for any complications or other medical accidents arising from or in connection with the use of or reliance upon any information in this web site. |